BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7024644)

  • 21. Adjuvant chemotherapy for breast cancer: an overview of NSABP findings.
    Fisher B; Redmond C; Elias EG; Evans J; Foster R; Jochimsen P; Lawrence W; Lerner H; LiCalzi N; Margolese R; Poisson R; Sachs S; Shibata H; Sutherland C; Wallack M
    Int Adv Surg Oncol; 1982; 5():65-90. PubMed ID: 7047408
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of chemotherapy in stage I breast cancer.
    Bonadonna G; Valagussa P
    Important Adv Oncol; 1989; ():151-60. PubMed ID: 2651285
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant chemotherapy in stage I breast cancer. More harm than benefit.
    Mueller CB
    Can Fam Physician; 1993 Oct; 39():2185-9. PubMed ID: 8219866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant chemotherapy for early-stage breast cancer.
    McArthur HL; Hudis CA
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):207-22. PubMed ID: 17512445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm.
    Russell CA
    Curr Womens Health Rep; 2002 Apr; 2(2):134-9. PubMed ID: 12116603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen/postmenopausal women. NIH consensus development.
    J Kans Med Soc; 1982 Oct; 83(10):511-3. PubMed ID: 6754835
    [No Abstract]   [Full Text] [Related]  

  • 27. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
    Buchholz TA; Lehman CD; Harris JR; Pockaj BA; Khouri N; Hylton NF; Miller MJ; Whelan T; Pierce LJ; Esserman LJ; Newman LA; Smith BL; Bear HD; Mamounas EP
    J Clin Oncol; 2008 Feb; 26(5):791-7. PubMed ID: 18258988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adjuvant therapy in breast neoplasms].
    Senn HJ
    Aktuelle Probl Chir Orthop; 1982; 22():52-60. PubMed ID: 6121514
    [No Abstract]   [Full Text] [Related]  

  • 31. Adjuvant chemotherapy of breast cancer. Summary of an NIH consensus statement.
    Br Med J; 1980 Sep; 281(6242):724-5. PubMed ID: 7000275
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigational new drugs in cancer chemotherapy.
    Peterson BA; Briscoe K
    Minn Med; 1979 Jul; 62(7):536-8. PubMed ID: 386073
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer research. Budget pressure puts high-profile study in doubt.
    Marshall E
    Science; 2007 Mar; 315(5818):1477. PubMed ID: 17363634
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant chemotherapy of breast cancer.
    Carroll RR
    J Med Assoc Ga; 1985 Nov; 74(11):758-9. PubMed ID: 3908609
    [No Abstract]   [Full Text] [Related]  

  • 36. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.
    J Natl Cancer Inst Monogr; 2001; (30):1-152. PubMed ID: 12083020
    [No Abstract]   [Full Text] [Related]  

  • 37. NIH/NCI Consensus Development Meeting on breast cancer screening. Response of the National Cancer Institute.
    Yale J Biol Med; 1978; 51(1):9-11. PubMed ID: 676352
    [No Abstract]   [Full Text] [Related]  

  • 38. NIH Consensus development conference summary: CEA as a cancer marker.
    J Tenn Med Assoc; 1982 Jan; 75(1):24-5. PubMed ID: 7087455
    [No Abstract]   [Full Text] [Related]  

  • 39. NCI's breast cancer clinical alert: rationale and results.
    DeVita VT; Hubbard SM
    Resid Staff Physician; 1989 Jul; 35(8):49-55. PubMed ID: 10303742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term tamoxifen trial halted.
    Marshall E
    Science; 1995 Dec; 270(5242):1562. PubMed ID: 7502061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.